Background RNA methylation has emerged as an active research field in diabetes mellitus
(DM) and its complications, while few bibliometric analyses have been performed. We aimed …

Cardiovascular diseases lead the mortality and morbidity disease metrics worldwide. A
multitude of chemical base modifications in ribonucleic acids (RNAs) have been linked with …

Background Cardiac fibrosis is a leading cause of cardiac dysfunction in patients with
diabetes. However, the underlying mechanisms of cardiac fibrosis remain unclear. This …

Activation of hepatic stellate cells (HSCs) is a central driver of liver fibrosis. Previous
investigations have identified various altered epigenetic landscapes during the cellular …

Diabetic cardiomyopathy (DCM) is a serious complication of diabetes mellitus (DM).
However, the precise molecular mechanisms remain largely unclear, and it is still a …

Diabetes mellitus (DM) and its related complications are among the leading causes of
disability and mortality worldwide. Substantial studies have explored epigenetic regulation …

The rapidly developing research field of epitranscriptomics has recently emerged into the
spotlight of researchers due to its vast regulatory effects on gene expression and thereby …

As the most common internal post‐transcriptional RNA modification in eukaryotic cells, N6‐
methyladenosine (m6A) performs a dynamic and reversible role in a variety of biological …

Development of heart failure (HF) after myocardial infarction (MI) is responsible for
premature death. Complex cellular and molecular mechanisms are involved in this process …

Fibrosis can occur in a variety of organs such as the heart, lung, liver and kidney, and its
pathological changes are mainly manifested by an increase in fibrous connective tissue and …